Gilead Sciences (NASDAQ: GILD) and Lakefront Biotherapeutics (Euronext & NASDAQ: LKFT) completed their acquisition of Ouro Medicines for $1.675 billion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE